Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopy or Allergy”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Early research (Phase 1)Study completedNCT03733353
What this trial is testing

EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Evelo Biosciences, Inc. 204
Early research (Phase 1)Study completedNCT04927195
What this trial is testing

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

Who this might be right for
Atopic DermatitisPsoriasisAsthma
Evelo Biosciences, Inc. 52
Testing effectiveness (Phase 2)Ended earlyNCT03809663
What this trial is testing

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Amgen 251
Early research (Phase 1)Study completedNCT00891709
What this trial is testing

LEO 29102 Single and Multiple Dose Study by Dermal Application

Who this might be right for
Atopic Dermatitis
LEO Pharma 64
Large-scale testing (Phase 3)Study completedNCT03422822
What this trial is testing

Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 3,166
Not applicableStudy completedNCT01164241
What this trial is testing

Natural History of Severe Allergic Inflammation and Reactions

Who this might be right for
PGM3 DeficiencyEosinophilic and/or Atopic DermatitisOSMR Deficiency+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 945
Large-scale testing (Phase 3)Ended earlyNCT05732454
What this trial is testing

Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by Injection

Who this might be right for
Atopic DermatitisAtopic Dermatitis, UnspecifiedEczema+1 more
Pfizer 58
Not applicableActive Not RecruitingNCT00568997
What this trial is testing

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Who this might be right for
Atopic Dermatitis
Bausch Health Americas, Inc. 8,000
Testing effectiveness (Phase 2)Study completedNCT01602341
What this trial is testing

Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Pfizer 86
Early research (Phase 1)Ended earlyNCT03846466
What this trial is testing

Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Kyowa Kirin Co., Ltd. 5
Testing effectiveness (Phase 2)UnknownNCT05694884
What this trial is testing

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

Who this might be right for
Atopic Dermatitis
ASLAN Pharmaceuticals 75
Testing effectiveness (Phase 2)Study completedNCT03903822
What this trial is testing

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 292
Large-scale testing (Phase 3)Looking for participantsNCT06807281
What this trial is testing

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Who this might be right for
Atopic Dermatitis
Pfizer 500
Early research (Phase 1)Ended earlyNCT06005792
What this trial is testing

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Xencor, Inc. 23
Not applicableUnknownNCT04265716
What this trial is testing

Topical L. Reuteri in Children With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Innovacion y Desarrollo de Estrategias en Salud 102
Testing effectiveness (Phase 2)Study completedNCT01808157
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Creabilis SA 188
Testing effectiveness (Phase 2)Study completedNCT00789880
What this trial is testing

Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3

Who this might be right for
Atopic DermatitisPsoriasis
National Institute of Allergy and Infectious Diseases (NIAID) 82
Not applicableStudy completedNCT02103972
What this trial is testing

Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Société des Produits Nestlé (SPN) 126
Large-scale testing (Phase 3)Looking for participantsNCT06880276
What this trial is testing

Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 360
Not applicableEnded earlyNCT00295737
What this trial is testing

Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma

Who this might be right for
AtopyRhinitisBronchial Asthma
Fraunhofer-Institute of Toxicology and Experimental Medicine 8
Next Page